SYMPTOM CONTROL IN ADVANCED PARKINSON’S DISEASE Vicky Travers PDNSUHMBT April 2012.

Slides:



Advertisements
Similar presentations
Parkinsons Disease Management in Primary Care. Introduction Progressive condition 1:500 whole population 1:50 of elderly 1:10 Nursing Home Residents.
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
End of Life Care for a Person With Parkinson Disease Recent Research and Clinical Implications.
Restless Leg Syndrome “ The most common disorder you have never heard of.”
Linda Pituch, Patient Services Manager, Parkinson’s Disease Foundation
PARKINSON’S DISEASE: AN OVERVIEW Living with Parkinson’s Disease Deborah Orloff, MPH, RN Chief Executive Officer Michigan Parkinson Foundation.
Non-motor Complications of Parkinson’s Disease and Management Valerie R. Suski, DO University of Pittsburgh Department of Neurology Pittsburgh Institute.
Parkinson’s Finding the cure Presentation
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
The PARticulars of Parkinson’s Disease
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
The Role of the Speech & Language Therapist Emma Burke Principal Speech & Language Therapist Bradford & Airedale tPCT Wednesday 12 th March 2008.
Neurology and Rehabilitation Target Day Parkinson’s Disease Dr Bruce Covell Amanda Horlor Linda Lloyd.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Prepared by: Muhammad Ibrahim khan BS.PT(Pak), MS.PT(Pak), NCC(AKUH), CHPE(KMU)
Harald Bjorndalen Adapted from lecture by Dr Zoe Campbell (Medical SpR)
Is it a neurodegenerative brain disorder that progresses slowly in most people.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Introduction – Anna Conlan Role Regional Care Development Advisor (RCDA)
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Huntington Disease Genetic Disorder Project Alaukika Desai AP Biology Period 3.
The management of advanced Parkinson’s disease Dr J Paul Milnes Consultant Physician Airedale NHS Trust.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Treatment of Parkinson’s Disease Thomas L. Davis, M.D. Associate Professor of Neurology Vanderbilt School of Medicine.
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
CONTINENCE ISSUES IN PEOPLE WITH PARKINSON’S DISEASE The role of the Field Officer.
Prognostic Indicator Guidance May 2011 Dr Peter Nightingale.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Group 5.  100+  Precise roles not known  3 categories.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
Implementing NICE guidance 2011 NICE clinical guideline 113 Generalised anxiety disorder in adults.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
ANTIPSYCHOTICS Katy and Zoë. Psychosis Mental disorder with a broad range of symptoms. Patients ‘lose touch with reality’ and present with: hallucinations.
Improvement of life quality and non motor symptoms relief in patients with advanced Parkinson's disease. Natalia Prican Andra Oltean Doctor Jozsef Attila.
Sarah Ehlers & Brendan Valentine Parkinson’s Disease.
Number of neurotransmitters  Neurotransmitters are chemicals capable of transmitting a signal from the pre-synaptic to the post synaptic neurone  Over.
SYMPTOMS: Tremors, stiff muscles Shuffling gait, Poor coordination Balance problems, Fatigue Speech & swallowing difficulties TREATMENTS: Medications.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Parkinson’s Disease Angela Duncan June Why I Chose This Subject Common neurodegenerative disorder / in Scotland Expected increase.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Management of Parkinson’s disease (in the acute medical ward) C. M. James MD FRCP FAcadMEd Consultant Physician Withybush Hospital, Pembrokeshire.
Parkinson Disease An Overview including Community Resources Presented by Christy Prezyna, PT Ellen Tomer, LMSW Members of HCR’s Parkinson’s Program.
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Parkinson’s Disease.
Sleep and Parkinson’s Disease
Living With and Managing Motor and Non-motor Symptoms
Understanding Parkinsons Disease
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Diagnosis Stage Parkinson’s Disease (PD) Guidelines
Introduction to Parkinson’s
WHAT I NEED TO KNOW AS A PATIENT AND A CAREGIVER
Drugs for Degenerative Diseases of the Nervous System
Neurodegenerative diseases
Management in Primary Care
Parkinson’s Disease Definitions Disease features Pathology
Lorna Gillies Parkinson’s Nurse Specialist
Palliative and End of Life Care for patients with Dementia
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

SYMPTOM CONTROL IN ADVANCED PARKINSON’S DISEASE Vicky Travers PDNSUHMBT April 2012

Parkinson’s Disease A fluctuating, progressive, neurological condition A fluctuating, progressive, neurological condition Results from degeneration of dopamine- producing neurones in substantia nigra Results from degeneration of dopamine- producing neurones in substantia nigra 1:500 (approx 120,000 people in UK) 1:500 (approx 120,000 people in UK) Increasingly prevalent with age Increasingly prevalent with age

Parkinson’s disease con’d Clinical diagnosis (NICE guidelines 2006) Clinical diagnosis (NICE guidelines 2006) Motor symptoms / non-motor symptoms Motor symptoms / non-motor symptoms Cause not known Cause not known Incurable but treatable Incurable but treatable Not life threatening, but can be life limiting Not life threatening, but can be life limiting

Core Symptoms for diagnosis Rigidity – raised tone in muscles Rigidity – raised tone in muscles Postural Instability – poor balance (often presents as a later feature) Postural Instability – poor balance (often presents as a later feature) Tremor – resting, asymmetrical, 70 % PwPD Tremor – resting, asymmetrical, 70 % PwPD Bradykinesia – slowness of movement Bradykinesia – slowness of movement

Progression of PD Individual progression rate Individual progression rate Individual manifestation of symptoms Individual manifestation of symptoms Individual response / side effects to medications Individual response / side effects to medications = Need for individualised care throughout disease trajectory = Need for individualised care throughout disease trajectory

Stages of Parkinson’s Disease Diagnosis Diagnosis Maintenance Maintenance Complex Complex Palliative Palliative

Palliative Care Should “Offer pain relief and meet needs for personal, social, psychological and spiritual support, in line with principles for palliative care” NSF for Long Term Neurological Conditions (Quality requirement 9) Advanced care planning Advanced care planning Progressive dopaminergic drug withdrawal Progressive dopaminergic drug withdrawal Analgesia, sedation and other palliative measures Analgesia, sedation and other palliative measures Primary and/or secondary care depending on circumstances Primary and/or secondary care depending on circumstances

Non-motor symptoms Cognition Cognition Pain Pain Autonomic symptoms Autonomic symptoms Sleep disturbance Sleep disturbance Communication Communication Swallowing Swallowing Weight loss Weight loss

Cognition Anxiety Anxiety Depression Depression Apathy Apathy Cognitive impairment Cognitive impairment Dementia Dementia Psychosis Psychosis

Symptom control Review PD meds Review PD meds ? Antidepressants – Mirtazapine ? Antidepressants – Mirtazapine CBT / talking therapy/ support CBT / talking therapy/ support Cholinesterase inhibitors Cholinesterase inhibitors Atypical antipsychotics – Quetiapine Atypical antipsychotics – Quetiapine Avoid Haloperidol!!! Avoid Haloperidol!!!

Pain Common and under-reported Common and under-reported Several types of pain [Primary or Secondary] Several types of pain [Primary or Secondary] Musculoskeletal – rigidity or dyskinesia Musculoskeletal – rigidity or dyskinesia Dystonic Dystonic Off phase pain Off phase pain Coat hanger pain – postural hypotension Coat hanger pain – postural hypotension Burning mouth, anal burning Burning mouth, anal burning Akathisia/restlessness - RLS Akathisia/restlessness - RLS

Symptom Control Careful assessment Careful assessment Exclude co-morbidities Exclude co-morbidities Review Parkinson’s medication – optimise dopaminergic treatment Review Parkinson’s medication – optimise dopaminergic treatment Analgesia Analgesia Complementary therapies Complementary therapies

Autonomic symptoms (dysautonomia) Postural Hypotension Postural Hypotension Sexual dysfunction Sexual dysfunction Bladder / bowel dysfunction Bladder / bowel dysfunction Sweating (Hyperhidrosis) Sweating (Hyperhidrosis) Drooling (Sialorrhoea) Drooling (Sialorrhoea)

Symptom Control Medication Medication Review PD meds, Hyoscine, Atropine drops sublingually (beware neuropsychiatric side effects) for drooling Domperidone (anecdotal evidence), Fludrocortisone, Midodrine for postural hypotension MDT MDT SALT, Continence team, nursing team, dietician

Sleep disturbance REM sleep behaviour disorder REM sleep behaviour disorder Akinesia / rigidity Akinesia / rigidity Dyskinesia Dyskinesia Restlessness Restlessness Urinary problems Urinary problems Hypersomnolence Hypersomnolence Bad dreams / hallucinations Bad dreams / hallucinations

Symptom Control Good sleep hygiene Good sleep hygiene Medication – Medication – Modafinal for hypersomnolence Clonazapam for REM sleep behaviour review Dopaminergic treatment review Dopaminergic treatment atypical antipsychotic atypical antipsychotic (beware side effects/ contraindications) MDT MDT

Communication Verbal and non-verbal Verbal and non-verbal Mask like facies (Hypomimia) Mask like facies (Hypomimia) reduced volume (Hypophonia) reduced volume (Hypophonia) “Stuttery” speech “Stuttery” speech Repitition of syllables or words (Palilalia) Repitition of syllables or words (Palilalia) Monotone and monopitch Monotone and monopitch

Symptom Control MDT especially SLT MDT especially SLT Alternative communication techniques Alternative communication techniques - Charts, amplifier, lightwriter, IPAD - Charts, amplifier, lightwriter, IPAD Education/ support for PwPD/ carers / family

Swallowing disorders Reduced tongue motility / co-ordination Reduced tongue motility / co-ordination Food remaining in epiglottic vallecula Food remaining in epiglottic vallecula Decreased ability to chew Decreased ability to chew Delay of pharyngeal swallow Delay of pharyngeal swallow Reduced laryngeal closure Reduced laryngeal closure Aspiration Aspiration

Symptom Control Speech and Language Therapy input Speech and Language Therapy input Dietician Dietician Medication review - ? Change preparation of medication Medication review - ? Change preparation of medication Thickened fluids Thickened fluids Observed / assisted feeding Observed / assisted feeding Education for Pwpd / Carers / family Education for Pwpd / Carers / family

Weight Loss Dyskinesia Dyskinesia Rigidity Rigidity Dysphagia Dysphagia Poor intake due to reduced ability / appetite Poor intake due to reduced ability / appetite

Symptom Control Dietician / SLT Dietician / SLT Medication review Medication review Maintain hydration Maintain hydration Skin care Skin care Mouth care Mouth care Assisted feeding Assisted feeding

Please Remember…… ……….Not all solutions work for all people………………. ……… Sometimes just being there is enough……………….

Thank you Thank you Any Questions? Any Questions? /

References National Service framework for Long Term Conditions. DoH (2005) Parkinson’s UK Parkinson’s UK Parkinson’s Disease. Diagnosis and Management in primary and secondary care. NICE (2006) Parkinson’s Disease. Diagnosis and Management in primary and secondary care. NICE (2006)